Advertisement

Effects of Tryptophan on the Development of Deoxycorticosterone Acetate (DOCA)-Induced Hypertension in Rats

  • M. J. Fregly
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 294)

Abstract

For some years, we have been interested in the role of neutral amino acids in the development and maintenance of hypertension. Our initial studies with tyrosine suggested that chronic dietary treatment with this essential amino acid could provide modest protection against the development of renal hypertension in rats (Lockley et al., 1985). However, it was considerably less effective in protecting against the development of deoxycorticosterone (DOCA)-induced hypertension (Henley et al., 1986).

Keywords

Chronic Treatment Antihypertensive Effect Isotonic Saline Neutral Amino Acid Heart Weight 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fregly, M.J., and Fater, D.C., 1986, Prevention of DOCA-induced hypertension by chronic treatment with tryptophan, Clin. Exp. Pharmacol. Physiol., 13: 767–776.PubMedCrossRefGoogle Scholar
  2. Fregly, M.J., Lockley, O.E., and Cade, J.R., 1988, Effect of chronic dietary treatment with L-tryptophan on the development of renal hypertension in rats, Pharmacology, 36: 91–100.PubMedCrossRefGoogle Scholar
  3. Fregly, M.J., Lockley, O.E., and Sumners, C., 1987a, Chronic treatment with L-5-hydroxytryptophan prevents the development of DOCA-salt-induced hypertension in rats, J. Hypertens., 5: 621–628.PubMedCrossRefGoogle Scholar
  4. Fregly, M.J., Lockley, O.E., van der Voort, J., Sumners C., and Henley, W.N., 1987b, Chronic dietary administration of tryptophan prevents development of DOCA-salt-induced hypertension in rats, Can. J. Physiol. Pharmacol., 65: 753–764.PubMedCrossRefGoogle Scholar
  5. Fregly, M.J., Sumners, C., and Cade, J.R., 1989, Effect of chronic dietary treatment with L-tryptophan on the maintenance of hypertension in spontaneously hypertensive rats, Can. J. Physiol. Pharmacol., 67: 656–662.PubMedCrossRefGoogle Scholar
  6. Henley, W.N., Fregly, M.J., Wilson, K.M., and Hathaway, S., 1986, Physiologic responses to chronic dietary tyrosine supplementation in DOCA-salt-treated rats, Pharmacology, 33: 334–347.PubMedCrossRefGoogle Scholar
  7. Lockley, O.E., Fregly, M.J., and Fater, D.C., 1985, Effect of L-p-tyrosine on the development of renal hypertension in rats, Pharmacology, 31: 132–149.PubMedCrossRefGoogle Scholar
  8. Sved, A.F., van Itallie, C.M., and Fernstrom, J.D., 1982, Studies on the antihypertensive action of L-tryptophan, J. Pharmacol. Exp. Therap., 221: 329–333.Google Scholar
  9. Wilson, K.M., Sumners, C., Hathaway, S., and Fregly, M.J., 1986, Mineralo-corticoids modulate central angiotensin II receptors in rats, Brain Res., 382: 87–96.PubMedCrossRefGoogle Scholar
  10. Wolf, W.A., and Kuhn, D.M., 1984, Effects of L-tryptophan on blood pressure in normotensive and hypertensive rats, J. Pharmacol. Exp. Therap., 230: 324–329.Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • M. J. Fregly
    • 1
  1. 1.Department of PhysiologyUniversity of Florida College of MedicineGainesvilleUSA

Personalised recommendations